By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Cerus Corporation 

2411 Stanwell Drive

Concord  California  94520   U.S.A.
Phone: 925-288-6000 Fax: 925-288-6001


SEARCH JOBS


Industry
Medical Device


Collaborations

MedImmune 





Company News
Cerus Corporation (CERS) Signs INTERCEPT Platelet Agreement With Sweden’s Largest Blood Product Supplier 2/27/2015 8:24:57 AM
Cerus Corporation (CERS) To Present At The Cowen and Company 35th Annual Health Care Conference On March 3, 2015 2/24/2015 11:09:37 AM
Cerus Corporation (CERS) To Release Fourth Quarter 2014 Results On February 26, 2015 2/13/2015 10:06:12 AM
Cerus Corporation (CERS) And SunCoast Blood Bank Enter Into Agreement For The Use Of INTERCEPT Platelets And Plasma 2/5/2015 10:46:02 AM
Cerus Corporation (CERS) And Blood Bank Of Delmarva Enter Into Agreement For The Use Of INTERCEPT Platelets And Plasma 2/4/2015 11:00:50 AM
Ash Stevens To Manufacture Amotosalen Active Pharmaceutical Ingredient For Cerus Corporation (CERS)' INTERCEPT Blood System 1/28/2015 8:08:16 AM
Cerus Corporation (CERS) Prices $70.0 Million Public Offering Of Common Stock 1/7/2015 11:08:44 AM
Cerus Corporation (CERS) Announces Proposed Public Offering Of Common Stock 1/6/2015 9:57:07 AM
Cerus Corporation (CERS) Reports EU Phase 3 Clinical Trial Of INTERCEPT Red Blood Cells Met Primary Endpoint 1/5/2015 8:41:03 AM
Cerus Corporation (CERS) Reports U.S. Phase 2 Clinical Trial Of INTERCEPT Red Blood Cells Met Primary Endpoint 12/22/2014 11:12:42 AM
12345678910...
//-->